Genetic analysis instead of chemotherapy.

Genetic analysis can relieve breast cancer patients on chemotherapy severe if this procedure is not required for curing. Unfortunately, this revolutionary discovery deter wide implementation in practice of the high price.
38-year-old American Sarah Jackson was sick   breast cancer Has gone through a mastectomy, doctors removed a cancerous tumor from her breast. And now the woman was going to have to make a choice. Oncologists offered her chemotherapy   in order to reduce the chance of recurrence of the deadly disease.

This procedure is not strictly necessary. In addition, many of us know, to some severe side effects it causes - from general weakness and nausea to hair loss. However, according to statistics, women aged Sarah has 40% chances to suffer a relapse breast cancer Which can result in death. That's why most of her peers, patients opt Chemotherapy .

But then Sarah found out that in some medical clinics in the US is used in full genetic test to determine the prognosis of breast cancer . Test Onkotip DX   designed specifically for patients with breast cancer With its help, doctors can check the activity of 11 genes in the tumor. These genes are directly linked to the spread of cancer. Froze their activities, experts may with a high degree of accuracy to determine what are the chances of recurrence of the tumor. So, is it worth to go through chemotherapy.

Sarah went through DX test Onkotip   and I saw that chemotherapy   it does not need. In any case, the woman also took a genetic test MammaPrint, which assesses the chances of tumor metastasis. Already, both tests used in clinical practice. However, it is quite expensive - the cost DX test Onkotip For example, in terms of our money it is about 100 thousand rubles.
However, we can hope that with the development of genetic medicine, this figure will be significantly reduced.

Industry News

Go back to the main page